Korro Bio Future Growth

Future criteria checks 0/6

Korro Bio's earnings are forecast to decline at 10.4% per annum while its annual revenue is expected to grow at 87.5% per year. EPS is expected to grow by 5.2% per annum.

Key information

-10.4%

Earnings growth rate

5.2%

EPS growth rate

Biotechs earnings growth28.8%
Revenue growth rate87.5%
Future return on equityn/a
Analyst coverage

Low

Last updated19 Sep 2024

Recent future growth updates

No updates

Recent updates

We Think Korro Bio (NASDAQ:KRRO) Needs To Drive Business Growth Carefully

Aug 15
We Think Korro Bio (NASDAQ:KRRO) Needs To Drive Business Growth Carefully

We Think Korro Bio (NASDAQ:KRRO) Can Afford To Drive Business Growth

Mar 30
We Think Korro Bio (NASDAQ:KRRO) Can Afford To Drive Business Growth

Earnings and Revenue Growth Forecasts

NasdaqCM:KRRO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026N/A-119N/A-1243
12/31/2025N/A-105N/A-1015
12/31/2024N/A-89N/A-915
6/30/2024N/A-85-83-69N/A
3/31/2024N/A-81-81-69N/A
12/31/2023N/A-81-75-67N/A
9/30/2023N/A-72-69-61N/A
6/30/2023N/A-69-73-64N/A
3/31/2023N/A-64-66-61N/A
12/31/2022N/A-58-59-54N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: KRRO is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: KRRO is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: KRRO is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: KRRO is forecast to have no revenue next year.

High Growth Revenue: KRRO is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if KRRO's Return on Equity is forecast to be high in 3 years time


Discover growth companies